Tiandi Science & Technology Co.Ltd (SHA:600582)
China · Delayed Price · Currency is CNY 5.77
-0.16 (-2.70%)
Mar 27, 2026, 11:30 AM CST
SHA:600582 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 29,242 | 30,142 | 29,575 | 26,972 | 23,260 |
Other Revenue | - | 384.64 | 352.71 | 443.82 | 310.93 |
| 29,242 | 30,527 | 29,928 | 27,416 | 23,571 | |
Revenue Growth (YoY) | -4.21% | 2.00% | 9.16% | 16.31% | 14.69% |
Cost of Revenue | 21,755 | 21,236 | 20,851 | 19,264 | 16,637 |
Gross Profit | 7,487 | 9,291 | 9,077 | 8,152 | 6,933 |
Selling, General & Admin | 3,732 | 3,615 | 3,527 | 3,146 | 2,852 |
Research & Development | 2,277 | 2,188 | 2,073 | 1,763 | 1,488 |
Other Operating Expenses | -70.05 | 88.4 | 126.88 | 208.07 | 175.34 |
Operating Expenses | 5,939 | 5,879 | 5,747 | 5,310 | 4,794 |
Operating Income | 1,548 | 3,412 | 3,329 | 2,843 | 2,139 |
Interest Expense | - | -22.32 | -22.55 | -21.53 | -21.35 |
Interest & Investment Income | 3,019 | 448.27 | 354.26 | 272.67 | 239.7 |
Currency Exchange Gain (Loss) | - | -0.04 | 2.56 | - | 0.56 |
Other Non Operating Income (Expenses) | 46.73 | -60.82 | -73.15 | 2.17 | -62.65 |
EBT Excluding Unusual Items | 4,614 | 3,777 | 3,590 | 3,096 | 2,296 |
Gain (Loss) on Sale of Investments | -1.61 | -1.29 | -3.75 | -7.3 | 0.9 |
Gain (Loss) on Sale of Assets | 4.8 | -3.87 | -16.82 | 7.96 | -52.75 |
Asset Writedown | 61.08 | -37.68 | -6.8 | -210.39 | -83.51 |
Legal Settlements | - | - | - | -2.01 | -12.85 |
Other Unusual Items | - | 268.12 | 232.22 | 179.12 | 183.61 |
Pretax Income | 4,678 | 4,002 | 3,795 | 3,064 | 2,332 |
Income Tax Expense | 889.69 | 555.88 | 616.72 | 530.18 | 363.08 |
Earnings From Continuing Operations | 3,788 | 3,446 | 3,178 | 2,533 | 1,969 |
Minority Interest in Earnings | -1,341 | -824.41 | -820.05 | -581.29 | -348.83 |
Net Income | 2,447 | 2,622 | 2,358 | 1,952 | 1,620 |
Net Income to Common | 2,447 | 2,622 | 2,358 | 1,952 | 1,620 |
Net Income Growth | -6.67% | 11.17% | 20.81% | 20.51% | 18.73% |
Shares Outstanding (Basic) | 4,140 | 4,142 | 4,137 | 4,136 | 4,143 |
Shares Outstanding (Diluted) | 4,140 | 4,142 | 4,137 | 4,136 | 4,143 |
Shares Change (YoY) | -0.03% | 0.10% | 0.04% | -0.17% | 0.21% |
EPS (Basic) | 0.59 | 0.63 | 0.57 | 0.47 | 0.39 |
EPS (Diluted) | 0.59 | 0.63 | 0.57 | 0.47 | 0.39 |
EPS Growth | -6.64% | 11.05% | 20.76% | 20.72% | 18.48% |
Free Cash Flow | -1,037 | 4,410 | 5,244 | 4,095 | 3,863 |
Free Cash Flow Per Share | -0.25 | 1.06 | 1.27 | 0.99 | 0.93 |
Dividend Per Share | - | 0.317 | 0.280 | 0.200 | 0.180 |
Dividend Growth | - | 13.21% | 40.00% | 11.11% | 20.00% |
Gross Margin | 25.61% | 30.44% | 30.33% | 29.73% | 29.42% |
Operating Margin | 5.29% | 11.18% | 11.12% | 10.37% | 9.08% |
Profit Margin | 8.37% | 8.59% | 7.88% | 7.12% | 6.87% |
Free Cash Flow Margin | -3.55% | 14.45% | 17.52% | 14.94% | 16.39% |
EBITDA | 2,244 | 4,138 | 4,045 | 3,525 | 2,861 |
EBITDA Margin | 7.67% | 13.56% | 13.52% | 12.86% | 12.14% |
D&A For EBITDA | 696.42 | 726.86 | 716.07 | 682.13 | 721.28 |
EBIT | 1,548 | 3,412 | 3,329 | 2,843 | 2,139 |
EBIT Margin | 5.29% | 11.18% | 11.12% | 10.37% | 9.08% |
Effective Tax Rate | 19.02% | 13.89% | 16.25% | 17.31% | 15.57% |
Revenue as Reported | - | 30,527 | 29,928 | 27,416 | 23,571 |
Advertising Expenses | - | 82.58 | 72.05 | 32.83 | 24.99 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.